We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Effect on Melanoma Risk of Genes Previously Associated With Telomere Length | JNCI: Journal of the National Cancer Institute | Oxford Academic Skip to Main Content
Article navigation

The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length

Mark M. Iles
Mark M. Iles
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
D. Timothy Bishop
D. Timothy Bishop
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
John C. Taylor
John C. Taylor
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Nicholas K. Hayward
Nicholas K. Hayward
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Myriam Brossard
Myriam Brossard
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Anne E. Cust
Anne E. Cust
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Alison M. Dunning
Alison M. Dunning
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Jeffrey E. Lee
Jeffrey E. Lee
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Eric K. Moses
Eric K. Moses
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
Lars A. Akslen
Lars A. Akslen
Affiliations of authors:
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds
,
Leeds
,
UK
(MMI, DTB, JCT, MHa, JRM, JANB, JHB);
Oncogenomics
(NKH),
Genetic Epidemiology
(NGM),
Inflammatory Bowel Diseases Laboratory
(GLRS),
Cancer Control Group
(DCW),
Statistical Genetics
(SM, MHL),
and Molecular Epidemiology
(GWM),
QIMR Berghofer Medical Research Institute
,
Brisbane
,
Australia
;
INSERM, UMR-946, Genetic Variation and Human Diseases Unit
,
Paris
,
France
(MB, FD);
Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie
,
Paris
,
France
(MB, FD);
Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney
,
Australia
(AEC);
Department of Oncology, University of Cambridge
,
Cambridge
,
UK
(AMD, PDPP);
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center
,
Houston, TX
(JEL);
Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
,
Crawley
,
Australia
(EKM, SVW);
Centre for Cancer Biomarkers CCBIO
(LAA)
and Gade Laboratory for Pathology
(AM),
Department of Clinical Medicine, University of Bergen
,
Bergen
,
Norway
;
Department of Pathology, Haukeland University Hospital
,
Bergen
,
Norway
(LAA);
Department of Pathology, Molecular Pathology
(PAA)
and Department of Dermatology
(PH),
Oslo University Hospital
,
Rikshospitalet, Oslo
,
Norway
;
Assistance Publique–Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes
,
Paris
,
France
(MFA);
Department of Dermatology
(EA)
and Oncogenics Unit
(EA, EF),
Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine
,
Tel Aviv
,
Israel
(EA);
Department of Internal Medicine and Medical Specialties, University of Genoa
,
Genoa
,
Italy
(GBS, EFPG);
Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital
,
Genoa
,
Italy
(GBS, EFPG);
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
,
Bethesda, MD
(KMB, AMG, MTL);
International Hereditary Cancer Center, Pomeranian Medical University
,
Szczecin
,
Poland
(TD, JL);
Department of Pathology and Laboratory Medicine
(DEE)
and Centre for Clinical Epidemiology & Biostatistics and Department of Biostatistics & Epidemiology
(PAK),
Perelman School of Medicine at the University of Pennsylvania
,
Philadelphia, PA
;
Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health
,
Baltimore, MD
(EMG);
Department of Dermatology
(NAG, RVD)
and Department of Clinical Genetics, Center of Human and Clinical Genetics
(NVDS),
Leiden University Medical Centre
,
Leiden
,
the Netherlands
;
Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital
,
Solna, Stockholm
,
Sweden
(JH, VH);
Department of Surgical Oncology
(MHo)
and Department of Molecular Diagnostics
(SN),
Institute of Oncology Ljubljana
,
Ljubljana
,
Slovenia
;
Department of Surgery
(CI)
and Departments of Oncology and Cancer Epidemiology
(HO),
Clinical Sciences, Lund University
,
Lund
,
Sweden
;
Department of Public Health
(RMM)
and Department of Medical Genetics
(JL, RMM),
University of Glasgow
,
Glasgow
,
UK
;
McGill University and Genome Quebec Innovation Centre
,
Montreal
,
Canada
(GML);
Commissariat à l’Energie Atomique, Institut de Génomique, Centre National de Génotypage
,
Evry
,
France
(GML);
Melanoma Unit, Dermatology Department, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona
,
Barcelona
,
Spain
(SP, JAPB);
CIBER de Enfermedades Raras, Instituto de Salud Carlos III
,
Barcelona
,
Spain
(SP, JAPB);
Department of Gastroenterology and Hepatology, Royal Brisbane & Womens Hospital
,
Herston
,
Australia
(GLRS);
School of Medicine, University of Queensland
,
Herston, Queensland
,
Australia
(GLRS);
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory
,
Cambridge
,
UK
(KAP, PDPP);
Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia
,
Sydney
,
Australia
(GJM);
Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College
,
Hanover, NH
(CIA).
Search for other works by this author on:
... Show more